- Home
- MRTN vs IMTX Comparison
MRTN vs IMTX Comparison
Compare MRTN & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRTN | IMTX |
|---|---|---|
| Founded | 1946 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MRTN | IMTX |
|---|---|---|
| Price | $13.07 | $8.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $17.50 | ★ $17.63 |
| AVG Volume (30 Days) | ★ 588.6K | 587.4K |
| Earning Date | 10-22-2026 | 11-16-2026 |
| Dividend Yield | ★ 1.86% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $1,131,455,000.00 | N/A |
| Revenue This Year | $0.87 | N/A |
| Revenue Next Year | $9.73 | N/A |
| P/E Ratio | $164.72 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.35 | $8.06 |
| 52 Week High | $18.48 | $12.41 |
Technical Indicators
Market Signals| Indicator | MRTN | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 28.45 | 48.46 |
| Support Level | $12.77 | $8.30 |
| Resistance Level | $13.00 | $10.51 |
| Average True Range (ATR) | 0.30 | 0.34 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 13.83 | 66.82 |
Price Performance
Historical ComparisonAbout MRTN Marten Transport Ltd.
Marten Transport Ltd is a temperature-sensitive and dry truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. The company operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services transporting food and other consumer packaged goods.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.